VTAE

VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE

Delisted

VTAE was delisted on the 24th of October, 2016.

15 hedge funds and large institutions have $45M invested in VITAE PHARMACEUTICALS INC COMMON STOCK in 2014 Q3 according to their latest regulatory filings, with 15 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
15
Holders Change
+15
Holders Change %
% of All Funds
0.44%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
15
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
NMC
1
NEA Management Company
Maryland
$19.9M 2,613,199 +2,613,199 New
AWMDMG
2
Austin W. Marxe & David M. Greenhouse
New York
$6.3M 825,000 +825,000 New
BI
3
BVF Inc
California
$5.08M 666,000 +666,000 New
Fidelity Investments
4
Fidelity Investments
Massachusetts
$4.67M 612,500 +612,500 New
WT
5
Wellcome Trust
United Kingdom
$3.96M 519,410 +519,410 New
Alyeska Investment Group
6
Alyeska Investment Group
Illinois
$1.39M 182,609 +182,609 New
JPMorgan Chase & Co
7
JPMorgan Chase & Co
New York
$953K 125,000 +125,000 New
IC
8
Intel Corp
California
$807K 105,751 +105,751 New
Millennium Management
9
Millennium Management
New York
$585K 76,624 +76,624 New
Marshall Wace
10
Marshall Wace
United Kingdom
$569K 74,568 +74,568 New
WAM
11
Weiss Asset Management
Massachusetts
$305K 40,000 +40,000 New
Deutsche Bank
12
Deutsche Bank
Germany
$248K 32,609 +32,609 New
SIP
13
Stoneridge Investment Partners
Pennsylvania
$169K 22,157 +22,157 New
GSC
14
Ground Swell Capital
South Carolina
$12K 1,521 +1,521 New
TRCT
15
Tower Research Capital (TRC)
New York
$1K 140 +140 New